Oncoceutics Pharmaceuticals, Inc. Employee Directory
PharmaceuticalsPennsylvania, United States11-50 Employees
Oncoceutics Pharmaceuticals, Inc. is a clinical-stage drug discovery and development company focused on oncology, pursuing a novel class of selective receptor antagonists. Its lead compound, ONC201, is an orally active small-molecule antagonist targeting DRD2, studied for effectiveness against advanced cancers and noted for tolerability. The company aims to advance oncology therapies by identifying and developing compounds with targeted mechanisms to address cancer biology. Based in Philadelphia, Pennsylvania, the organization operates within the pharmaceutical manufacturing industry and has a relatively small- to mid-size employee footprint. Recent activity includes collaboration efforts with external partners and research institutions to support various clinical and preclinical programs related to its compound portfolio.